NCT07349173

Brief Summary

This study aims to evaluate the representation of action peripersonal space (PPS) in subjects suffering from unilateral segmental exclusion syndrome of the upper limb compared to healthy control subjects. Segmental exclusion is defined by non-use or under-use of a limb segment without central nervous system damage. The study hypothesizes that this syndrome leads to a modification (shrinkage) of the PPS representation. Participants will perform reachability judgments in a Virtual Reality (VR) environment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
20mo left

Started Dec 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Dec 2025Jan 2028

Study Start

First participant enrolled

December 4, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 8, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 16, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

January 8, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

Peripersonal SpaceVirtual RealityBody SchemaReachability Judgment

Outcome Measures

Primary Outcomes (1)

  • Judgment Error of Reachability

    The Judgment Error of Reachability is a single composite metric calculated as: ((DMA-p - DMA-r) / DMA-r) × 100, expressed as a percentage (%). Both DMA-p (Perceived Maximum Reachable Distance) and DMA-r (Real Maximum Reachable Distance) are measured in centimeters, and their ratio yields a single dimensionless percentage score.

    Day 1 (During the 40-minute VR assessment)

Secondary Outcomes (5)

  • Body Perception Disturbance Score

    Day 1 (Before VR task)

  • Functional Impairment Score (400-Point Hand Assessment)

    Day 1

  • Anxiety and Depression Score (HAD)

    Day 1

  • Kinesiophobia Score (Tampa Scale)

    Day 1

  • Pain Catastrophizing Score (PCS)

    Day 1

Study Arms (2)

Patients with Exclusion

Patients presenting with unilateral segmental exclusion of the upper limb or part of the hand evolving for more than 3 months.

Behavioral: Reachability Judgment Task in VR.

Healthy Controls

symptomatic volunteers with no history of upper limb impairment with sequelae.

Behavioral: Reachability Judgment Task in VR.

Interventions

Participants wear an Oculus Quest 2 VR headset. They first perform a motor task to measure Real Reachable Distance (DMA-r). Then, they perform a perceptual task where they must judge, without moving, if a virtual object is reachable (DMA-p). The test evaluates different spatial planes (front, 45° right, 45° left) and heights (shoulder, navel).

Healthy ControlsPatients with Exclusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

he study population consists of two groups recruited at the Institut Régional de Réadaptation (Centre Louis Pierquin, UGECAM Nord-Est) in Nancy, France. Patients with Exclusion: Participants are selected from patients receiving routine care (full hospitalization or day hospital) at the center. They are identified based on a functional assessment ("Bilan 400 points") showing specific impairments related to unilateral upper limb exclusion evolving for more than 3 months. Healthy Controls: Asymptomatic volunteers are recruited through the social or family network of the investigators and current participants, as well as via posters displayed in the UGECAM centers.

You may qualify if:

  • Age ≥ 18 years.
  • No contraindication to force work in daily activities.

You may not qualify if:

  • Affiliated to a social security scheme.
  • Able to understand simple orders.
  • Age ≥ 18 years.
  • No history of upper limb impairment with sequelae.
  • Visual impairments.
  • Central neurological pathology.
  • Unstabilized psychiatric pathology.
  • Communication or comprehension difficulties.
  • Under legal protection or unable to consent.
  • Pregnant or breastfeeding women.
  • Cervical pathology contraindicating VR headset use.
  • Epilepsy.
  • Inability to stand for 40 minutes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Régional de Médecine Physique et de Réadaptation (IRR), Centre Louis Pierquin.

Nancy, 54000, France

RECRUITING

MeSH Terms

Conditions

Complex Regional Pain SyndromesPersonal Space

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesSpatial BehaviorBehavior

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2026

First Posted

January 16, 2026

Study Start

December 4, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

March 16, 2026

Record last verified: 2026-03

Locations